Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05201612
Title Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC). (PEMBROLA)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol Multidisciplinario del Cancer Digestivo

colorectal cancer


Olaparib + Pembrolizumab

Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.